Grafa News and Videos — Page 653

Titan Machinery (NASDAQ:TITN) reported a double-digit decline in first-quarter revenue, swinging to a net loss as a broader cyclical slowdown in global agricultural and construction markets continues to weigh on heavy equipment retail volumes.

Burning Rock Biotech (NASDAQ:BNR) reported an 18.9% drop in first-quarter revenue for fiscal year 2026, as lower volumes across its core diagnostic testing and pharmaceutical services lines countered ongoing cost-containment measures.

Designer Brands (NYSE:DBI) reported a slight expansion in its first-quarter top-line revenue, driven by strong growth within its wholesale division that helped offset softening demand across its core brick-and-mortar storefront network.

Parsons (NYSE:PSN) has secured an additional $73 million contract from the Air Force Research Laboratory to continue supporting its Global Application Research, Development, Engineering and Maintenance (GARDEM) mission.

Nathan’s Famous (NASDAQ:NATH) reported higher top-line revenue for fiscal year 2026, driven by growth in its foodservice and franchise segments, even as surging input costs chipped away at overall profit margins ahead of its planned private ownership transition.

Tims China (NASDAQ:THCH), the exclusive operator of Tim Hortons coffee shops in China, reported a double-digit drop in first-quarter revenue and a widening net loss as intense promotional discounting and shifting consumer traffic continued to squeeze the country's fast-casual dining sector.

GSK (NYSE:GSK) has entered into a definitive agreement to acquire Nuvalent (NASDAQ:NUVL) for $10.6 billion in cash, marking a substantial expansion of the British drugmaker's oncology franchise through the purchase of three targeted lung cancer therapies.

Vertical Aerospace (NYSE:EVTL) completed the maiden piloted flight of its newest full-scale prototype aircraft, initiating an expanded flight testing campaign ahead of a major design milestone.

Novanta (NASDAQ:NOVT) has entered into a definitive agreement to acquire Riverpoint Medical, a developer and manufacturer of specialized minimally invasive surgical consumables, for an upfront cash consideration of $1.2 billion.

Powerlaw (NASDAQ:PWRL) reported a sequential increase in its monthly net asset value, driven by positive valuation updates across its investment portfolio as of the end of May.